Literature DB >> 31371411

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.

Clément Bailly1,2, Thomas Carlier1,2, Alina Berriolo-Riedinger3, Olivier Casasnovas4, Emmanuel Gyan5, Michel Meignan6, Anne Moreau7, Barbara Burroni8, Loïc Djaileb9, Remy Gressin10, Anne Devillers11, Thierry Lamy12,13, Catherine Thieblemont14, Olivier Hermine15, Françoise Kraeber-Bodéré1,2,16, Steven Le Gouill17,18, Caroline Bodet-Milin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31371411      PMCID： PMC6939504          DOI： 10.3324/haematol.2019.223016

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Indolent mantle cell lymphoma.

Authors:  Eric D Hsi; Peter Martin
Journal:  Leuk Lymphoma       Date:  2013-09-24

2.  Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

Authors:  Steven Le Gouill; Catherine Thieblemont; Lucie Oberic; Anne Moreau; Krimo Bouabdallah; Caroline Dartigeas; Gandhi Damaj; Thomas Gastinne; Vincent Ribrag; Pierre Feugier; Olivier Casasnovas; Hacène Zerazhi; Corinne Haioun; Hervé Maisonneuve; Roch Houot; Fabrice Jardin; Eric Van Den Neste; Olivier Tournilhac; Katell Le Dû; Franck Morschhauser; Guillaume Cartron; Luc-Matthieu Fornecker; Danielle Canioni; Mary Callanan; Marie C Béné; Gilles Salles; Hervé Tilly; Thierry Lamy; Remy Gressin; Olivier Hermine
Journal:  N Engl J Med       Date:  2017-09-28       Impact factor: 91.245

3.  Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.

Authors:  Arne Kolstad; Anna Laurell; Mats Jerkeman; Kirsten Grønbæk; Erkki Elonen; Riikka Räty; Lone Bredo Pedersen; Annika Loft; Trond Velde Bogsrud; Eva Kimby; Per Boye Hansen; Unn-Merete Fagerli; Herman Nilsson-Ehle; Grete Fossum Lauritzsen; Anne Kristine Lehmann; Christer Sundstrom; Marja-Liisa Karjalainen-Lindsberg; Elisabeth Ralfkiaer; Mats Ehinger; Jan Delabie; Hans Bentzen; Jukka Schildt; Kamelia Kostova-Aherdan; Henrik Frederiksen; Peter de Nully Brown; Christian H Geisler
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

4.  Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Dreyling; E Campo; O Hermine; M Jerkeman; S Le Gouill; S Rule; O Shpilberg; J Walewski; M Ladetto
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

5.  Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.

Authors:  Anthony R Mato; Jakub Svoboda; Tatyana Feldman; Tania Zielonka; Harry Agress; David Panush; Mitchell Miller; Patrick Toth; Paul M Lizotte; Sunita Nasta; Stuart Goldberg; Emeline Chong; Steven Schuster; Andrew L Pecora; Andre Goy
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

6.  Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

Authors:  Caroline Bodet-Milin; Cyrille Touzeau; Christophe Leux; Mehmet Sahin; Anne Moreau; Hervé Maisonneuve; Nadine Morineau; Henry Jardel; Philippe Moreau; Céline Gallazini-Crépin; Pascal Gries; Rémy Gressin; Jean-Luc Harousseau; Mohamad Mohty; Philippe Moreau; Françoise Kraeber-Bodere; Steven Le Gouill
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-29       Impact factor: 9.236

7.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

8.  Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.

Authors:  Veronika Bachanova; Linda J Burns; Kwang Woo Ahn; Ginna G Laport; Görgün Akpek; Mohamed A Kharfan-Dabaja; Taiga Nishihori; Edward Agura; Philippe Armand; Samantha M Jaglowski; Mitchell S Cairo; Amanda F Cashen; Jonathon B Cohen; Anita D'Souza; César O Freytes; Robert Peter Gale; Siddhartha Ganguly; Nilanjan Ghosh; Leona A Holmberg; David J Inwards; Abraham S Kanate; Hillard M Lazarus; Adriana K Malone; Reinhold Munker; Alberto Mussetti; Maxim Norkin; Tim D Prestidge; Jacob M Rowe; Prakash Satwani; Tanya Siddiqi; Patrick J Stiff; Basem M William; Baldeep Wirk; David G Maloney; Sonali M Smith; Anna M Sureda; Jeanette Carreras; Mehdi Hamadani
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-14       Impact factor: 5.742

9.  Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?

Authors:  Meirav Kedmi; Irit Avivi; Elena Ribakovsky; Noam Benyamini; Tima Davidson; Elinor Goshen; Tamar Tadmor; Arnon Nagler; Abraham Avigdor
Journal:  Leuk Lymphoma       Date:  2014-03-07

Review 10.  Interest of FDG-PET in the Management of Mantle Cell Lymphoma.

Authors:  Clément Bailly; Thomas Carlier; Cyrille Touzeau; Nicolas Arlicot; Françoise Kraeber-Bodéré; Steven Le Gouill; Caroline Bodet-Milin
Journal:  Front Med (Lausanne)       Date:  2019-04-09
View more
  14 in total

1.  Reply to E. Laffon et al.

Authors:  Clément Bailly; Thomas Carlier; Françoise Kraeber-Bodéré; Steven Le Gouill; Caroline Bodet-Milin
Journal:  Haematologica       Date:  2020-01       Impact factor: 9.941

2.  Prognostic value of 18F-FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.

Authors:  Eric Laffon; Roger Marthan
Journal:  Haematologica       Date:  2020-01       Impact factor: 9.941

3.  Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.

Authors:  Jorge E Jimenez; Dong Dai; Guofan Xu; Ruiyang Zhao; Tengfei Li; Tinsu Pan; Linghua Wang; Yingyan Lin; Zhangyang Wang; David Jaffray; John D Hazle; Homer A Macapinlac; Jia Wu; Yang Lu
Journal:  Clin Nucl Med       Date:  2022-03-01       Impact factor: 7.794

4.  Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in relapsed and refractory aggressive lymphoma.

Authors:  Takeshi Sugio; Shingo Baba; Yasuo Mori; Goichi Yoshimoto; Kenjiro Kamesaki; Shuichiro Takashima; Shingo Urata; Takahiro Shima; Kohta Miyawaki; Yoshikane Kikushige; Yuya Kunisaki; Akihiko Numata; Katsuto Takenaka; Hiromi Iawasaki; Toshihiro Miyamoto; Kousei Ishigami; Koichi Akashi; Koji Kato
Journal:  Int J Hematol       Date:  2022-06-14       Impact factor: 2.319

Review 5.  Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.

Authors:  Clément Bailly; Caroline Bodet-Milin; Mickaël Bourgeois; Sébastien Gouard; Catherine Ansquer; Matthieu Barbaud; Jean-Charles Sébille; Michel Chérel; Françoise Kraeber-Bodéré; Thomas Carlier
Journal:  Cancers (Basel)       Date:  2019-08-31       Impact factor: 6.639

6.  18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.

Authors:  Li Wang; Ping Dong; Weiming Hu; Bole Tian
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

7.  The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study.

Authors:  Domenico Albano; Riccardo Laudicella; Paola Ferro; Michela Allocca; Elisabetta Abenavoli; Ambra Buschiazzo; Alessia Castellino; Agostino Chiaravalloti; Annarosa Cuccaro; Lea Cuppari; Rexhep Durmo; Laura Evangelista; Viviana Frantellizzi; Sofya Kovalchuk; Flavia Linguanti; Giulia Santo; Matteo Bauckneht; Salvatore Annunziata
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

8.  The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.

Authors:  Kristina Noring; Mattias Carlsten; Kristina Sonnevi; Björn Engelbrekt Wahlin
Journal:  BMC Cancer       Date:  2021-05-04       Impact factor: 4.430

9.  Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.

Authors:  Simone Krebs; Julia G Barasch; Robert J Young; Christian Grommes; Heiko Schöder
Journal:  Ann Lymphoma       Date:  2021-06-30

10.  Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.

Authors:  Cédric Rossi; Marie Tosolini; Pauline Gravelle; Sarah Pericart; Salim Kanoun; Solene Evrard; Julia Gilhodes; Don-Marc Franchini; Nadia Amara; Charlotte Syrykh; Pierre Bories; Lucie Oberic; Loïc Ysebaert; Laurent Martin; Selim Ramla; Philippine Robert; Claire Tabouret-Viaud; René-Olivier Casasnovas; Jean-Jacques Fournié; Christine Bezombes; Camille Laurent
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.